Your browser doesn't support javascript.
loading
A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer.
Jin, Fangfang; Yang, Liuqing; Wang, Weixiang; Yuan, Na; Zhan, Shoubin; Yang, Ping; Chen, Xi; Ma, Tonghui; Wang, Yanbo.
Affiliation
  • Jin F; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Yang L; Department of Infectious Diseases, Department of Gastrointestinal Surgery, The First People's Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu, China.
  • Wang W; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced I
  • Yuan N; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Zhan S; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced I
  • Yang P; Department of Clinical Laboratory, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China.
  • Chen X; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced I
  • Ma T; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. matonghui@njucm.edu.cn.
  • Wang Y; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced I
Mol Cancer ; 20(1): 95, 2021 07 17.
Article in En | MEDLINE | ID: mdl-34273975
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / RNA, Transfer / Biomarkers, Tumor / RNA, Small Untranslated Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / RNA, Transfer / Biomarkers, Tumor / RNA, Small Untranslated Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: China Country of publication: United kingdom